Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of two formulations of Sabal serrulata in benign prostatic hyperplasia
2006-003532-30Phase 3Completed
- Sponsor
- Berlin-Chemie AG
- Start
- Oct 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of saw palmetto fruit extract in benign prostatic hyperplasia (BPH) (3 arms), sponsored by Berlin-Chemie AG. Primary endpoints: IPSS response rate at 12 months and Change in IPSS from baseline to 12 months. Started Oct 2006; status: completed.
02
Drugs
saw palmetto fruit extract
03
Conditions
benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on 2006-003532-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-003532-30.